Lymphoma
Conditions
Interventions
None listed
Sponsors
Japan Children's Cancer Group
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: lymphoma using WHO calcification (exclude leukemia) Under 30 year-old at initial diagnosis Patients who agree with registration of JPLSG CHM-14 Patients who agree with registration of JPLSG PL-19 (this study)
Exclusion criteria
Exclusion criteria: Lymphoblastic leukemia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival period of each lymphoma | — |
Secondary
| Measure | Time frame |
|---|---|
| Event free survival period of each lymphoma relapse and progression time of each lymphoma occurrence rate of second malignancy in each lymphoma Overall survival period according each treatment method Event free survival period according each treatment method Relapse time according each treatment method | — |
Countries
Japan
Contacts
Public ContactDaiki Hori
Sapporo Hokuyu hospital Department of Hematology/Oncology for Children and Adolescents
Outcome results
None listed